Boomray Pharmaceuticals Co., Ltd.
PrivateLast Round
Series A
Sep 2, 2022
Total Funding Raised
$43.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Boomray Pharmaceuticals Co., Ltd. is a biotechnology company that develops innovative radioligand therapies for precision oncology diagnostics and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Boomray Pharmaceuticals Co., Ltd. Comparables
Compare Boomray Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Eli Radiopharma Co., Ltd. | 87% | |
| C-Ray Therapeutics | 85% | |
| Full-Life Technologies | 85% |
Boomray Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 2, 2022 |
Boomray Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Puhua Capital | Series A |
| HongShan Capital Group (HSG) | Series A |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 606% MoM.
- Apr 22, 2026
Monthly visitors increased 2221% MoM, reaching 1.7K.
Recent news
Latest coverage and updates
- partners_withSep 22, 2026
BoomRay Pharmaceutical Co., Ltd. partnered with Novartis Pharmaceuticals Corporation on Sep 22nd '26.
Boomray Pharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Boomray Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Boomray Pharmaceuticals Co., Ltd. a public or private company?
Boomray Pharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Boomray Pharmaceuticals Co., Ltd.?
Boomray Pharmaceuticals Co., Ltd. is a private company with no public stock price. Caplight tracks Boomray Pharmaceuticals Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Boomray Pharmaceuticals Co., Ltd. worth (valuation)?
Valuation information for Boomray Pharmaceuticals Co., Ltd. is not publicly available.
Can I buy Boomray Pharmaceuticals Co., Ltd. stock?
Boomray Pharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Boomray Pharmaceuticals Co., Ltd.'s last funding round?
Boomray Pharmaceuticals Co., Ltd.'s most recent funding round was Series A on September 2, 2022.
Who are the main investors in Boomray Pharmaceuticals Co., Ltd.?
Key investors in Boomray Pharmaceuticals Co., Ltd. include HongShan Capital Group (HSG).
Will Boomray Pharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Boomray Pharmaceuticals Co., Ltd..
How can I track Boomray Pharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Boomray Pharmaceuticals Co., Ltd.'s secondary market activity and sign up for updates.